Prophylactic Ebola Treatment Market: Are Monoclonal Antibody-Based Pre-Exposure Prophylactics the Future of Ebola Virus Prevention?
The persistent threat of Ebola virus disease outbreaks in Central and West Africa — compounded by the potential for international spread and the devastating mortality rates of 25-90% in untreated cases — is driving unprecedented investment in prophylactic treatment strategies, with the Prophylactic Ebola Treatment Market reflecting monoclonal antibody platforms as the most promising...
0 Commentarios 0 Acciones 31 Views 0 Vista previa
Patrocinados